Patents by Inventor Scott Allen LOILER

Scott Allen LOILER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENE THERAPY FOR THE TREATMENT OF GALACTOSEMIA
    Publication number: 20210299275
    Abstract: Provided herein are recombinant AAV vectors encoding a GALT protein. Also provided in this disclosure are compositions and methods for the treatment of galactosemia.
    Type: Application
    Filed: August 30, 2019
    Publication date: September 30, 2021
    Applicant: RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
    Inventor: Scott Allen Loiler
  • INCREASING TISSUE SPECIFIC GENE DELIVERY BY CAPSID MODIFICATION
    Publication number: 20210087584
    Abstract: Modified capsid proteins, isolated polynucleotides, methods for the preparation of modified capsid proteins, recombinant viral particles, recombinant expression systems for the generation of modified viral particles, and methods of gene editing and regulation are provided herein.
    Type: Application
    Filed: March 14, 2019
    Publication date: March 25, 2021
    Applicant: Research Intitute at Nationwide Children's Hospital
    Inventor: Scott Allen LOILER
  • ENHANCED MODIFIED VIRAL CAPSID PROTEINS
    Publication number: 20200157570
    Abstract: Modified capsid proteins, isolated polynucleotides, methods for the preparation of modified capsid proteins, recombinant viral particles, recombinant expression systems for the generation of modified viral particles, and methods of gene editing and regulation are provided herein.
    Type: Application
    Filed: June 4, 2018
    Publication date: May 21, 2020
    Applicant: Research Institute at Nationwide Children's Hospital
    Inventor: Scott Allen LOILER